SCHEMBL240509

SCHEMBL240509

NC(=O)CC[C@H](N)C(N)=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.68
BLM P54132 1/20 0.68
PMP22 Q01453 1/20 0.68
KMT2A Q03164 1/20 0.68
DPP4 P27487 1/20 0.47
DPP8 Q6V1X1 1/20 0.47
DPP9 Q86TI2 1/20 0.47
GRM8 O00222 1/20 0.44
GRM6 O15303 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GSR P00390 1/20 0.44
CYP1A2 P05177 1/20 0.44
GRIK1 P39086 1/20 0.44
GRM5 P41594 1/20 0.44
GRIA1 P42261 1/20 0.44
GRIA2 P42262 1/20 0.44
GRIA3 P42263 1/20 0.44
SLC1A3 P43003 1/20 0.44
SLC1A2 P43004 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1262932 1.00 ALOX15 (0.68) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL240508 1.00 ALOX15 (0.68) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL1332756 1.00 ALOX15 (0.68) ALOX15BLMPMP22KMT2ADPP4
Hydrochloric Acid SCHEMBL2962431 0.97 ALOX15 (0.65) ALOX15BLMPMP22KMT2ADPP4
Hydrochloric Acid SCHEMBL27609113 0.97 ALOX15 (0.65) ALOX15BLMPMP22KMT2ADPP4
Bromide SCHEMBL11569711 0.97 ALOX15 (0.65) ALOX15BLMPMP22KMT2ADPP4
Sulfuric Acid SCHEMBL28398263 0.91 PMP22 (0.58) ALOX15BLMPMP22KMT2ADPP4
SCHEMBL8209380 0.89 KMT2A (0.54) ALOX15BLMPMP22KMT2ADPP4
Glutamine SCHEMBL9164032 0.85 PMP22 (0.76) ALOX15BLMPMP22KMT2AGRM8
SCHEMBL9823333 0.84 BLM (0.50) ALOX15BLMPMP22KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260083865-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2026-03-26 US claimed
EP-4696699-A1 ? OPIOID RECEPTOR AGONIST AND USE THEREOF Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-18 EP claimed
EP-4688995-A1 HYDROPHILICALLY MODIFIED SILICONE PRESSURE SENSITIVE ADHESIVE Momentive Performance Materials Inc. (US) 2026-02-11 EP claimed
EP-4688996-A1 SELF-CATALYZING SILICONE COMPOSITION, ADHESIVES FORMED THEREFROM, AND A METHOD OF MAKING SAME Momentive Performance Materials Inc. (US) 2026-02-11 EP claimed
US-20260027071-A1 COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND (KR) 2026-01-29 US claimed
EP-4638637-A1 IMPROVED BONDING RESIN Stora Enso Oyj (FI) 2025-10-29 EP claimed
EP-4638636-A1 IMPROVED BONDING RESIN Stora Enso Oyj (FI) 2025-10-29 EP claimed
EP-4638635-A1 IMPROVED BONDING RESIN Stora Enso Oyj (FI) 2025-10-29 EP claimed
US-20250270404-A1 BONDING RESIN STORA ENSO OYJ (FI) 2025-08-28 US claimed
US-20250270405-A1 BONDING RESIN STORA ENSO OYJ (FI) 2025-08-28 US claimed
US-5506340-A POLYPEPTIDE HAVING ACETYLATED AMINO TERMINAL AND/OR AMIDATED CARBOXY TERMINAL CENTECOR, INC. (US) 1996-04-09 US claimed
WO-1995026744-A1 TUMOR NECROSIS FACTOR INHIBITORS CENTOCOR, INC. (US) 1995-10-12 WO claimed
EP-0473700-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1992-03-11 EP claimed
EP-0193113-B1 PROCESS FOR OPTICALLY ISOMERIZING OPTICALLY ACTIVE ALPHA-AMINO ACID AMIDES AND PROCESS FOR PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACIDS MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1992-01-22 EP claimed
WO-1990014429-A1 AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES NOVO NORDISK A/S (DK) 1990-11-29 WO claimed
US-4918196-A HEATING IN PRESENCE OF STRONG BASE, SOLVENT OR SOLVENT-FREE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1990-04-17 US claimed
EP-0193113-A1 Process for optically isomerizing optically active alpha-amino acid amides and process for producing optically active alpha-amino acids MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1986-09-03 EP claimed
EP-0018793-B1 PEPTIDES AND PROCESS FOR THEIR PREPARATION ORTHO PHARMACEUTICAL CORPORATION (US) 1983-11-09 EP claimed
US-4250086-A Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH2 ORTHO PHARMACEUTICAL CORPORATION (US) 1981-02-10 US claimed
EP-0018793-A2 Peptides and process for their preparation ORTHO PHARMACEUTICAL CORPORATION (US) 1980-11-12 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260083865-A1 PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF KLK3, FOLH1, PSMA1 ALOX15 4547/4885BLM 4494/4885PMP22 4325/4885
US-20260027071-A1 COMPOSITION FOR PROMOTING COLLAGEN PRODUCTION COMPRISING AMIDATED AMINO ACID COL2A1, COL14A1, GLS ALOX15 2921/4885BLM 4688/4885PMP22 363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.